These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28117622)

  • 21. Correlation between drug dissolution and polymer hydration: a study using texture analysis.
    Li H; Gu X
    Int J Pharm; 2007 Sep; 342(1-2):18-25. PubMed ID: 17548178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer blends for controlled release coatings.
    Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2008 Jan; 125(1):1-15. PubMed ID: 18022722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug.
    Mamani PL; Ruiz-Caro R; Veiga MD
    Int J Pharm; 2015 Oct; 494(1):235-43. PubMed ID: 26276258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix tablets based on a carrageenan with the modified-release of sodium riboflavin 5'-phosphate.
    Buchholcz G; Kelemen A; Sovány T; Pintye-Hódi K
    Pharm Dev Technol; 2015; 20(6):676-83. PubMed ID: 24758384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
    Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
    AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mathematical modeling of drug dissolution.
    Siepmann J; Siepmann F
    Int J Pharm; 2013 Aug; 453(1):12-24. PubMed ID: 23618956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissolution of mesalazine modified release tablets under standard and bio-relevant test conditions.
    Garbacz G; Rappen GM; Koziolek M; Weitschies W
    J Pharm Pharmacol; 2015 Feb; 67(2):199-208. PubMed ID: 25557626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Relationship Between the Evolution of an Internal Structure and Drug Dissolution from Controlled-Release Matrix Tablets.
    Kulinowski P; Hudy W; Mendyk A; Juszczyk E; Węglarz WP; Jachowicz R; Dorożyński P
    AAPS PharmSciTech; 2016 Jun; 17(3):735-42. PubMed ID: 26335419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico and in vitro methods to optimize the performance of experimental gastroretentive floating mini-tablets.
    Eberle VA; Häring A; Schoelkopf J; Gane PA; Huwyler J; Puchkov M
    Drug Dev Ind Pharm; 2016; 42(5):808-17. PubMed ID: 26307090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
    Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
    Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amorphous drug dispersions with mono- and diacyl lecithin: On molecular categorization of their feasibility and UV dissolution imaging.
    Gautschi N; Van Hoogevest P; Kuentz M
    Int J Pharm; 2015 Aug; 491(1-2):218-30. PubMed ID: 26129840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling accelerated and decelerated drug release in terms of fractional release rate.
    Weiss M
    Eur J Pharm Sci; 2015 Feb; 68():51-5. PubMed ID: 25486334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride.
    Likar MD; Mansour HL; Harwood JW
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):543-51. PubMed ID: 15975755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
    Ramadhani N; Shabir M; McConville C
    Int J Pharm; 2014 Nov; 475(1-2):514-22. PubMed ID: 25218186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
    Zhou Y; Chu JS; Li JX; Wu XY
    Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
    Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface-active derivative of inulin (Inutec® SP1) is a superior carrier for solid dispersions with a high drug load.
    Srinarong P; Hämäläinen S; Visser MR; Hinrichs WL; Ketolainen J; Frijlink HW
    J Pharm Sci; 2011 Jun; 100(6):2333-42. PubMed ID: 21254065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crushed tablets: does the administration of food vehicles and thickened fluids to aid medication swallowing alter drug release?
    Manrique YJ; Lee DJ; Islam F; Nissen LM; Cichero JA; Stokes JR; Steadman KJ
    J Pharm Pharm Sci; 2014; 17(2):207-19. PubMed ID: 24934549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current approaches for in vitro drug release study of long acting parenteral formulations.
    Dadhaniya TM; Sharma OP; Gohel MC; Mehta PJ
    Curr Drug Deliv; 2015; 12(3):256-70. PubMed ID: 25666683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.